Axxelis Lightning Exchange #5 – ‘A journey against all odds – the first mRNA splice modifier to market’
On Thursday 9th December the highly anticipated 4th Axxelis Lightning Exchange event was held. The subject matter this time around was the fascinating and expansive topic; ‘The convergence of health and technology: more than a gadget’.
Read More
Axxelis Lightning Exchange #4 – ‘The convergence of health and technology: more than a gadget’
On Thursday 9th December the highly anticipated 4th Axxelis Lightning Exchange event was held. The subject matter this time around was the fascinating and expansive topic; ‘The convergence of health and technology: more than a gadget’.
Read More
Axxelis Lightning Exchange #3 – ‘TRUST in Expert Networks.’
“To show trust is to behave as if the future were certain” – Luhmann. Wednesday 29th September saw our highly anticipated third Axxelis Lightning Exchange event take place.
Read More
How are patients impacted by current healthcare practices? Was the big question at our recent ‘Lightning Exchange’ event.
Shared experiences and insights were the order of the day that stimulated further discussion on this increasingly important topic, particularly in the wake of a global pandemic. You can view this enlightening interactive discussion below.
Read More
Market Access the HOT TOPIC for our inaugural Lightning Exchange Event
Our very 1st ‘virtual’ Lightning Exchange took place on Thursday 25th March, with the hot topic of ‘Market access – cracking the challenges and shaping the future’ being our first subject for discussion, presented by 2 of our Axxelis partner’s, Peter Mitterhofer and Stephane Rouault. Following the excellent feedback from this event, we wanted to […]
Read More
Reimagining how life sciences work will be done in the next normal
As COVID-19 continues to alter our lives, both personally, as well as professionally, this fascinating article from McKinsey considers how life sciences work will be done in the next normal. “COVID-19 has accelerated new ways of working in the life sciences industry that have been talked about for years—chief among them a shift to patient and customer […]
Read More
Most leaders think remote working will hit productivity – this is why
Our homes have, for many, become our place of work. While there are obvious benefits, there are also drawbacks for the employee and the employer. Here, the World Economic Forum looks at the effects of homeworking and productivity. According to the report: Employers expect to move about 44% of workers to work from home during […]
Read More
COVID-19 impact: rethinking how to plan for and run clinical trials
COVID has had a huge impact on the processes of effective clinical trials. This has led to a huge pivot in the approach to carrying out clinical trials. In this article from Deloitte, they delve into the new ideas and practicalities when planning and running clinical trials. “Clinical trials are vital to find out whether […]
Read More
Turning Data into Decisions
To successfully turn a biologically active molecule into a beneficial and commercially successful medicine, many important decisions need to be taken along the way. These decisions are about choices that will drive development and commercialization strategy. The masses of data and parameters can make the required analysis very challenging. Particularly in resource-constrained environments and under […]
Read More
The Bridge on the River Choluteca
Charles Darwin once said, “it is not the strongest of the species that survives, nor the most intelligent. It is the one that is most adaptable to change”. A terrific metaphor for this, the story of the Choluteca Bridge. As you can see from the story in the picture, the Choluteca Bridge started as a […]
Read More
Putting secular wisdom practices at the core of dealing with change – Axxelis’s value proposition
Change is part of life. As one of our Axxelis members already highlighted in a 2018 newsletter, the healthcare ecosystem is going through a big transformation forcing its stakeholders to work closely and to share knowledge and expertise as never before in order to develop solutions that will save lives. Patient-centric strategies, pay-for-performance contracts and […]
Read More
Returning to work and the psychological impact caused by COVID-19
As the world tentatively returns back to the new state of normal, we look at the psychological impact of the COVID-19 pandemic on employees, and how positive leadership can lessen the impact on employees returning to work. In our first article, McKinsey examines, in detail, psychological safety, emotional intelligence, and leadership in a time of […]
Read More
THE RACE FOR A VACCINE
The race to find a suitable vaccine for COVID-19 is getting ever closer to the finishing line. Here we look at the latest developments from the pharmaceutical industry. ‘While development of a large-scale vaccine would traditionally take years to scale-up to mass production, the unprecedented scope of the pandemic has accelerated the timeline to months, […]
Read More
The digital moment has arrived in the pharmaceutical industry
The current pandemic has brought about rapid change within the world of healthcare and pharmaceuticals. Here we look at the pairing of data science and technologies so to provide patients and physicians with a positive experience. ‘The global COVID-19 pandemic sparked a seismic shift in the adoption and scaling of digital technologies across the healthcare […]
Read More
The science of healthy ageing
COVID-19 has alienated the older generation; the over 70’s are now viewed as vulnerable and frail. With this particular demographic being forced into isolation to shield against the coronavirus, the general consensus seems to be that their time of a fulfilled life is over. But how true is this? In these fascinating articles, we look at […]
Read More
COVID-19 and Pharma
The COVID-19 pandemic has presented the pharmaceutical industry with the opportunity to strengthen what some view as a tainted image. Abbott Laboratories is winning effusive praise for its introduction of a rapid Covid-19 test. Johnson & Johnson has ramped-up its advertising on Twitter to promote the company’s research into a vaccine for Covid-19. It is […]
Read More
Evaluating Pharma Amid COVID-19
While the pharmaceutical industry is less vulnerable to market dynamics during a downturn as compared to other industries, this unpredictable environment amid the COVID-19 pandemic has pharma reconsidering their portfolios and pipeline assets, supply chains, API sourcing, and manufacturing. In this article, Arda Ural, Ph.D., a Principal and the Americas Industry Markets Leader, Health Sciences […]
Read More
Critical Thinking and effective communication strategy
Good thinking and communication skills aren’t optional these days – they’re essential. Products are purchased, ideas are adopted, subject matter is mastered all with the help of either the spoken or the written word. Indeed a promotion – even being hired in the first place – often depends on how well you structure your thinking […]
Read More
BUSINESS NEWS – ENGAGING BUSINESS BRAINS
The great regulatory catch-up Medical device manufacturers have a lot to learn from the pharmaceutical sector which, for well over a decade, has been subject to the sorts of rigorous electronic reporting standards soon to be faced by device producers. To ignore the parallels and start from scratch with MDR and other standards now being imposed by […]
Read More
INDUSTRY NEWS – FASCINATING INDUSTRY INSIGHTS
How Will The Failure Of Biogen’s Alzheimer’s Drug, Aducanumab, Impact R&D? The landscape of experimental Alzheimer’s disease (AD) drugs is strewn with failures, so much so that it has been referred to as “an unrelenting disaster zone”. Recognizing the greatly increasing number of patients with this disease, many biopharma companies have invested a lot of resources […]
Read MoreSCIENCE NEWS – THE LATEST NEWS FROM THE SCIENTIFIC COMMUNITY
Roche technology measures Parkinson’s disease fluctuations This is another fine example of how smartphones could be used to good effect in modern day medicine. Roche Pharma Research & Early Development (pRED) has developed a smartphone-based monitoring system for those with Parkinson’s disease (PD) that complements the traditional physician-led assessments with automated tests that continuously measure […]
Read More
Tradition vs. Innovation – Is digital always best?
Every business wants to push the boundaries and be ahead of the curve in developing and launching new products, services, approaches to workflow and audience engagement. Not to mention data gathering and sharing. After all, that is what makes them succeed or fail as a company, and the healthcare sector is no different. But it […]
Read More
SCIENCE NEWS – THE LATEST NEWS FROM THE SCIENTIFIC COMMUNITY
Machine Learning Applied to EEG Data May Serve as Huntington’s Biomarker, Study Suggests A method called quantitative electroencephalography (qEEG) enables the identification of Huntington’s gene carriers and could become a disease biomarker, according to a pilot study. The research, “EEG may serve as a biomarker in Huntington’s disease using machine learning automatic classification,” appeared in the journal Scientific Reports. Progressive […]
Read MoreINDUSTRY NEWS – FASCINATING INDUSTRY INSIGHTS
Rising Physician Dissatisfaction in Europe Signals an Urgent Need for Change In the two years since we last surveyed physicians working on the front line of European healthcare, their discontent has risen to an alarming level. Many say they would not recommend their hospital as a place to work or to receive care. Physicians and […]
Read More
BUSINESS NEWS – ENGAGING BUSINESS BRAINS
The top ten trends impacting pharma communications Global healthcare is facing massive disruption. Pressures such as an ‘always on’ social media and the new opportunities presented by partnership and collaboration with developers of ground-breaking technologies are contributing to a new, exciting and innovative era, transforming the way in which health companies need to behave in […]
Read More
SCIENCE NEWS – THE LATEST NEWS FROM THE SCIENTIFIC COMMUNITY
Neuroscientists target Alzheimer’s “silent stage” The latest research into what is known as the “silent stage” of Alzheimer’s disease has prompted many experts to believe that early intervention may offer the best chance of therapeutic success. The “silent stage” of Alzheimer’s concerns what goes on inside the brain before symptoms appear and is today a […]
Read MoreINDUSTRY NEWS – FASCINATING INDUSTRY INSIGHTS
Video – 7 Ways Artificial Intelligence Is Transforming Healthcare One of the biggest impacts of new technology – and perhaps the most life-changing – will be felt in healthcare. Diagnosis of illness will be fast and efficient, and medicine will be highly personalised. Wearable technology will be the norm, and we’ll know we are sick before […]
Read More
BUSINESS NEWS – ENGAGING BUSINESS BRAINS
Mark of success The advances we’ve seen in the discovery and use of genetic biomarkers in recent years have been remarkable. Look at the recent revolution in home DNA testing kits – now a burgeoning new industry expected to be worth £261m by 2022. For the healthcare sector, the sky is the limit in terms […]
Read More
AXXELIS INSIGHTS – MEET THE PARTNERS
STEPHANE ROUAULT Stephane has 25 years of experience in data and system management and strategic innovation in drug development. At Roche, Stephane led the Strategic Innovation Hub. Key deliverables included agreeing the digital healthcare strategy, structure and network to support innovative activities and projects. He also, introduced a patient-centric approach in Clinical Trial design, including […]
Read More
Axxelis Insights – Meet the Partners
This month, the spotlight is on Axxelis Partner, Elena Sebokova. A well-recognized expert in diabetes and metabolic diseases served in various executive positions in pharma industry. Elena has been instrumental in biomarker discovery and personalised healthcare with a strong commitment to system biology and system medicine. Previously, Elena’s academic career spanned over 25 years in […]
Read More
Science News – the latest news from the scientific community
How to make the gene-editing tool CRISPR work even better Scientists have found conclusive evidence that Cas9, the most popular enzyme currently used in CRISPR gene editing, is less effective and precise than one of the lesser-used CRISPR proteins, Cas12a. Because Cas9 is more likely to edit the wrong part of a plant’s or animal’s […]
Read More
Industry News – Fascinating industry insights
TRANSITION demonstrated that ENTRESTO® (sacubitril/valsartan) can be safely initiated in patients shortly after an acute heart failure episode in stable NYHA Class II-IV HFrEF patients1 The results of TRANSITION demonstrated that early initiation of Entresto in-hospital or soon after discharge (i.e. in a 2-week window) showed similar tolerability.1 Tolerability was measured by proportion of patients achieving the 97/103 mg […]
Read More
BUSINESS NEWS – ENGAGING BUSINESS BRAINS
The Cure for Pharma’s Commercial Productivity Woes Pharmaceutical companies find it increasingly hard to deliver growth from their in-market portfolio or through product launches. Categories have gotten more crowded, making market share gains harder to eke out. Price increases, the main lever in markets such as the US, are more difficult to impose. Doctors in […]
Read More
Industry News – Fascinating industry insights
FDA approves Epidiolex, the first marijuana-based pharmaceutical On June 25th the FDA-approved Epidiolex (GW Pharmaceuticals plc), a cannabidiol (CBD) based drug to treat both Lennox-Gastaut and Dravet syndromes, two rare forms of epilepsy. Epidiolex is the first drug product based on an active ingredient in marijuana approved for use in the US and is the first […]
Read More
Science News – the latest news from the scientific community
Why GV and Canaan Backed Pact Pharma’s Hyperpersonalised Cancer Approach Pact Pharma Inc. has raised $120 million in venture financing to tackle one of the most complex forms of personalized medicine proposed to date: neoantigen-targeted T cells. Backed by Alphabet Inc.’s GV, the company is using an informatics mindset to create hyper-personalized therapies. The challenge […]
Read MoreBusiness News – Engaging Business Brains
3,000 Years of Business History in Two Minutes The prevailing paradigm that has underpinned business for the past 50 years is beginning to shift. Over the next 10 years, we will see the nature of the firm reshaped by the cumulative impact of external and internal forces. But this change has happened many times before… […]
Read More
Getting Ready to Launch
In today’s business environment, the only thing that is constant is change. The healthcare industry is undergoing a transformational journey in response to external changes: patient empowerment and expansion of digital health, the expanding power of payers and complexity of health care systems, evolving expectations of business conduct and growing pressure on resources. Launch preparation […]
Read More
A Meeting of Axxelis Minds
On Thursday 7th June 2018 a number of our Axxelis Partners met in Basel for a team gathering to discuss current and future projects. The very successful meeting was held at Gasthof zum Goldenen Sternen. With Axxelis growing, and with so much to discuss, out Autumn meeting is already being arranged.
Read More
Axxelis Insights – Meet the Partners
This month we turn the spotlight on Co-Founder, Eric Gillain. An experienced multi-cultural executive with a background in healthcare and consumer goods, Eric’s experience includes leading the Global Marketing Services organization for Novartis Pharma, driving the OTC business unit in France and managing several product categories for Roche and Procter & Gamble. As CEO of […]
Read More
Axxelis – Springing into Action
During the past two months, Axxelis Partners have been working tirelessly to produce innovative solutions to new and exciting business opportunities as they have arisen.
Read More
Industry News – Fascinating industry insights
Shire Shares Gain After Deal With Takeda Nears Completion
Read More
Science News – the latest news from the scientific community
Eye implant made from stem cells could halt macular degeneration
Read More
Axxelis Insights – Meet the Partners
This month we shine the spotlight on Axxelis Partner, Karen Spruce, Director of Greensplash Ltd, a successful and award-winning design and medical communications agency based in the heart of Cheshire in the UK.
Read More
Great news – Welcome to the AXXELIS Newsletter!
First of all, a heartfelt thanks to each and every one of you who are helping make our AXXELIS Community so amazing!
Read More
Business News – engaging business brains
The Harvard Business School’s Kraft Precision Medicine Accelerator is tackling a series of initiatives that will position patients to help drive improvements in both clinical care and…
Read More
Industry News – Fascinating industry insights
Bristol-Myers lassos the next big thing in I/O, grabs ‘214 rights in a record $3.6B deal with Nektar
Read More
Science News – the latest news from the scientific community
Stem Cell-Based Vaccine Could Give Broad Immunity Against Cancers
Read More
The Firm of the Future
In the world of the firm, something is changing. It’s not that your local bookstore went out of business.
Read More
Axxelis Expert Connections Continues To Grow
Great news – the Axxelis family is continuing to expand with fantastic new additions to our Expert Group.
Read More
Our community is our heartbeat
With the AXXELIS Connect Club, our goal is to bring together strong talents in a deep and lively community of friends.
Read More
Message from Alex, our founder and CEO
The importance of being fit for competitive innovation is increasingly vital…
Read More